That's how I felt in the beginning. However, now that they are open to selling data to drug companies...I'm not so sure my data is going to be used strictly to benefit humanity.
I'm not even sure there is a one-size-fits-all answer to such things. That particular case seemed to be obviously one of greed, but most cases aren't as obvious. The most obvious (to me) would be some sort of price justification on new drugs, which takes into account r&d (to include a portion of failed drugs, but not advertising), manufacturing, and other actual costs with a certain percent of profits - with increases only rising with inflation or by going through the justification process yet again (to account for changes in manufacturing costs, for example). I don't see that happening soon, though.
DEF CON 25 - John Sotos - Genetic Diseases to Guide Digital Hacks of the Human Genome
idk the Chief Medical Officer of Intel considers genetic testing in general a pretty damn huge security risk and you completely neglect the whole bio weapons aspect.